Skip to main content
. 2023 Apr 4;32(4):423–433. doi: 10.1089/jwh.2022.0133

Table 2.

Fibroid-Specific History

  Myomectomy, N = 446 (30.4%) Hysterectomy, N = 741 (50.6%) Endometrial ablation, N = 123 (8.4%) Uterine artery embolization, N = 155, (10.6%)
Age first told have fibroids (years), mean (SD) 33.9 (6.5) 38.6 (8.2) 40.4 (6.7) 37.8 (8.0)
Age first have fibroid symptoms (years), mean (SD) 33.4 (7.4) 37.6 (8.9) 38.2 (8.6) 37.1 (9.0)
Duration of symptoms (years), mean (SD) 5.1 (6.0) 7.3 (8.0) 6.4 (7.8) 7.5 (7.9)
Family history of fibroids, n (%) 258 (57.8) 376 (50.7) 59 (48.0) 82 (52.9)
Current contraception, n (%) 278 (62.3) 502 (67.7) 97 (78.9) 96 (61.9)
Regular, predictable menses, n (%) 338 (75.8) 419 (56.5) 66 (53.7) 89 (57.4)
History of anemia, n (%) 201 (45.1) 412 (55.6) 60 (48.8) 112 (72.3)
Requiring transfusion, n (%) 37 (8.3) 77 (10.4) 13 (10.6) 24 (15.5)
Total fibroid volume (cm3), median (Q1, Q3)a 293 (120–552) 132 (33–310) 5 (1–18) 154 (74–339)
Uterine volume (cm3), median (Q1, Q3)a 586 (300–1024) 415 (218–786) 174 (118–256) 538 (293–949)
Number of fibroids measured, median (Q1, Q3)a 2 (1–4) 2 (1–3) 1 (1–1) 2 (1–3)
Any fibroid symptoms, n (%) 419 (93.9) 701 (94.6) 119 (96.7) 150 (96.8)
Bleeding symptoms 342 (76.7) 629 (84.9) 118 (95.9) 135 (87.1)
Menses ≥7 days 204 (45.7) 448 (60.5) 92 (74.8) 95 (61.3)
Heavy menses 314 (70.4) 580 (78.3) 113 (91.9) 122 (78.7)
Bleeding between periods 182 (40.8) 386 (52.1) 59 (48.0) 76 (49.0)
Frequent urination 278 (62.3) 428 (57.8) 63 (51.2) 111 (71.6)
Nocturia 250 (56.1) 440 (59.4) 68 (55.3) 105 (67.7)
Abdominal bloating 322 (72.2) 535 (72.2) 96 (78.0) 129 (83.2)
Abdominal/pelvic pressure 326 (73.1) 545 (73.5) 83 (67.5) 122 (78.7)
Appear pregnant 198 (44.4) 314 (42.4) 43 (35.0) 66 (42.6)
Discomfort during intercourse 186 (41.7) 325 (43.9) 53 (43.1) 65 (41.9)
Pelvic pain requiring meds 161 (36.1) 358 (48.3) 57 (46.3) 73 (47.1)
Subfertility 62 (13.9) 84 (11.3) 19 (15.4) 17 (11.0)
Multiple miscarriages 15 (3.4) 37 (5.0) 13 (10.6) 10 (6.5)
Nonmenstrual pain 40 (9.0) 104 (14.0) 30 (24.4) 19 (12.3)
Any prior treatment, n (%) 68 (15.2) 155 (20.9) 10 (8.1) 24 (15.5)
Abdominal myomectomy 28 (6.3) 49 (6.6) 2 (1.6) 7 (4.5)
Hysteroscopic myomectomy 18 (4.0) 25 (3.4) 2 (1.6) 5 (3.2)
Laparoscopic/robotic myomectomy 14 (3.1) 31 (4.2) 2 (1.6) 4 (2.6)
Vaginal myomectomy 9 (2.0) 17 (2.3) 1 (0.8) 3 (1.9)
Focused ultrasound 2 (0.4) 6 (0.8) 0 (0.0) 0 (0.0)
Endometrial ablation 5 (1.1) 32 (4.3) 1 (0.8) 6 (3.9)
Radiofrequency ablation 0 (0.0) 1 (0.1) 0 (0.0) 0 (0.0)
Uterine artery embolization 3 (0.7) 23 (3.1) 1 (0.8) 1 (0.6)
a

Q1,Q3 respond to the 25th and 75th percentile.